AI assistant
Sending…
InspireMD, Inc. — Director's Dealing 2025
Jan 10, 2025
34187_dirs_2025-01-10_be2139d0-924f-404b-bff4-ff30650afa44.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2025-01-07
Reporting Person: ROUBIN GARY S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-07 | Common Stock | A | 32491 | — | Acquired | 534279 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-07 | Options to purchase common stock (right to buy) | $2.71 | A | 14836 | Acquired | 2035-01-07 | Common Stock (14836) | Direct |
Footnotes
F1: These shares of common stock represent shares of restricted stock that shall vest on January 7, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.
F2: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.
More from InspireMD, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Board/Management Information
2026
May 22
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 20
Capital/Financing Update
2026
Apr 3
Capital/Financing Update
2026
Apr 3
Annual Report
2026
Mar 18
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11
Major Shareholding Notification
2026
Feb 2